BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
Biotech/Pharma - Investor
Aratana Therapeutics (PETX) Announces Full Exercise Of Underwriters' Option To Purchase Additional Shares 9/19/2014
Lpath, Inc. (LPTN) Announces $12.5 Million Registered Direct Offering 9/19/2014
DiaGenic ASA – Notice Of Extraordinary General Meeting 9/19/2014
ICON Plc Announces Completion Of $40 Million Share Buyback And A Further Share Buyback Program For Up To $100 Million 9/19/2014
PharMerica Announces New Senior Secured Credit Agreement 9/19/2014
Agilent Technologies Inc. (A) Board Of Directors Approves Separation Of Keysight, Declares Special Dividend Distribution Of Keysight Stock 9/18/2014
Can-Fite BioPharma (CFBI) Files June 30, 2014 Interim Financial Statements 9/18/2014
Oncothyreon Inc. (ONTY) Announces Proposed Public Offerings 9/18/2014
Oncothyreon Inc. (ONTY) Prices $40 Million Concurrent Public Offerings Of Common Stock And Preferred Stock 9/18/2014
Nuvilex (NVLX) Updates Shareholders On Recent Activities And Discusses Future Plans For Development Of Treatments For Cancer And Diabetes 9/18/2014
Tokai Pharmaceuticals Announces Pricing Of Initial Public Offering 9/17/2014
Relypsa, Inc. (RLYP) Announces New Employment Inducement Grants 9/17/2014
FEI Company Announces Quarterly Cash Dividend Of $0.25 Per Share 9/17/2014
Synereca Pharmaceuticals Announces Financing Led By Accele Venture Partners 9/17/2014
Novadaq Corp. To Host Analyst & Investor Day On November 17, 2014 9/17/2014
Aratana Therapeutics (PETX) Announces Proposed Public Offering 9/17/2014
Chindex International, Inc. (CHDX) Stockholders Approve Merger 9/17/2014
RXi Pharmaceuticals (RXII) Strengthens Intellectual Property Portfolio 9/17/2014
Auxilium Pharmaceuticals (AUXL) Responds To Unsolicited Proposal From Endo International plc (ENDP) 9/17/2014
Celator Pharmaceuticals, Inc. To Ring The NASDAQ Stock Market Closing Bell On September 17, 2014 9/17/2014
Aastrom Biosciences, Inc. (ASTM) Announces Closing Of Public Offering Of Common Stock And Full Exercise Of Underwriters' Option To Purchase Additional Shares 9/17/2014
MGB Biopharma Limited Secures $6.4 MillionTo Advance Its Novel Lead Antibacterial, MGB-BP-3, Into Clinical Development 9/17/2014
Syneron Inc. Announces Details For Upcoming Investor Meeting 9/16/2014
Valeant Pharmaceuticals International (VRX) Announces Redemption Of All Of The Outstanding $500.0 Million Aggregate Principal Amount Of Its 6.75% Senior Notes Due 2017 9/16/2014
Nordic Nanovector: Final Result Of The Subsequent Offering 9/16/2014
Pivotal Therapeutics Inc. Grants Incentive Stock Options 9/16/2014
CorMedix (CRMD) Amends And Restates Outstanding Securities To Remove Provisions Causing Derivative Liability Classification 9/16/2014
Opexa Therapeutics (OPXA) Announces Termination of Public Offering of Common Stock 9/16/2014
Allergan Inc. (AGN) To Hold Special Meeting Of Stockholders On Originally Scheduled Date Of December 18 Without Restriction 9/16/2014
Opexa Therapeutics (OPXA) Announces Proposed Public Offering Of Common Stock 9/16/2014
Celator Pharmaceuticals, Inc. To Ring The NASDAQ Stock Market Closing Bell 9/16/2014
Inovio Pharmaceuticals (INO) Begins Trading On NASDAQ Global Select Market Exchange 9/15/2014
PDL BioPharma, Inc. (PDLI) Completes Regular Quarterly Dividend Payment 9/15/2014
Antibe Therapeutics Inc. Commences Trading On The U.S. OTCQX Marketplace 9/15/2014
Ampio Pharmaceuticals, Inc. (AMPE) Announces Webcast For Annual Shareholder Meeting 9/15/2014
Akebia Therapeutics, Inc. (AKBA) To Ring The NASDAQ Stock Market Opening Bell 9/12/2014
Abbott Announces New $3 Billion Share Repurchase Program, Declares Dividend 9/12/2014
Novavax, Inc. (NVAX) To Host 2nd Annual Analyst And Investor Meeting 9/12/2014
NPS Pharmaceuticals, Inc. (NPSP) Stock Trading Halted Today; FDA Advisory Committee To Review Natpara® Biologics License Application 9/12/2014
Veeva Systems, Inc. To Host Analyst Day On Sept. 17, 2014 9/12/2014
Kolltan Pharmaceuticals Inc. Files Registration Statement for Proposed Initial Public Offering 9/12/2014
Aastrom Biosciences, Inc. (ASTM) Announces Pricing Of Public Offering Of Common Stock 9/11/2014
Resolutions Adopted At Extraordinary General Meeting Of Shareholders Of Recipharm AB 9/11/2014
Orexigen Therapeutics, Inc. (OREX) To Host Conference Call And Webcast At 8:30 AM Eastern Time September 11, 2014 9/11/2014
Portage Announces Proposed Private Placement 9/11/2014
Resolutions Adopted At Extraordinary General Meeting Of Shareholders Of Recipharm AB 9/11/2014
Roche (RHHBY) Again Ranked Most Sustainable Healthcare Company In The Dow Jones Sustainability Indices 9/11/2014
Fibrocell Science, Inc. Hosting R&D Day On September 24, 2014 9/11/2014
Intuitive Surgical, Inc. (ISRG) Reports New Employee Option Grants For September 2014 9/10/2014
Peregrine Pharmaceuticals, Inc. (PPHM) Declares Quarterly Dividend On Its Series E Convertible Preferred Stock 9/10/2014
BrainStorm Cell Therapeutics Inc. Provides Update On NASDAQ Uplisting Process 9/10/2014
TNI BioTech Announces Results Of Annual Shareholders Meeting 9/9/2014
Polydex Pharmaceuticals (POLXF) Reports Equipment Upgrades And Continued Profitability 9/9/2014
Aegerion Pharmaceuticals, Inc. (AEGR) Grants Stock Options Under Inducement Program 9/9/2014
Relmada Therapeutics Provides Its First Corporate Update As A Public Company 9/9/2014
Regeneus (ASX:RGS) Share Purchase Plan Closes Oversubscribed 9/9/2014
MabVax Therapeutics, Inc. Receives Stockholder Approval For Name Change And Reverse Stock Split Resulting From Merger With Telik, Inc. (TELK) 9/9/2014
Clovis Oncology (CLVS) Announces Exercise In Full By Initial Purchasers Of Their Option To Purchase An Additional $37.5 Million Aggregate Principal Amount Of The Company’s 2.50% Convertible Senior Notes Due 2021 9/9/2014
ContraFect Corporation (CFRXU) Announces Separation Of Units Sold In IPO 9/9/2014
PDL BioPharma, Inc. (PDLI) Announces Conversion Rate Adjustments For Convertible Notes 9/8/2014
EndoStim Files Registration Statement For Proposed Initial Public Offering Of Common Stock 9/8/2014
Intrexon Corporation Announces Filing Of Form S-3 Shelf Registration Statement 9/8/2014
Matinas BioPharma Approved To Trade On OTCQB Venture Stage Marketplace 9/8/2014
NeoStem, Inc. Letter To Shareholders 9/8/2014
Asterias Biotherapeutics Announces Record Date For Distribution Of BioTime (BTX) Warrants To Holders Of Asterias Series A Common Stock 9/8/2014
BioBlast Pharma (ORPN) To Ring The NASDAQ Stock Market Opening Bell 9/8/2014
La Jolla Pharmaceutical Company (LJPC) To Provide Corporate Overview At The Rodman & Renshaw 16th Annual Global Investment Conference 9/8/2014
Axxess Pharma, Inc. Provides Shareholder Update 9/8/2014
Panther Biotechnology Announces A 6-1 Forward Stock Split To Increase Liquidity Of Their Common Stock And Intent To List On The NYSE Or NASDAQ 9/8/2014
Loxo Oncology (LOXO) Announces Closing Of Initial Public Offering And Partial Exercise Of Over-Allotment Option 9/5/2014
Ablynx (ABLYF) Establishes Sponsored Level I ADR Programme In The United States 9/5/2014
Allergan Inc. (AGN) Provides Update On Written Requests From Pershing Square Regarding Special Meeting Of Stockholders 9/5/2014
InterMune, Inc. (ITMN) Announces Anticipated Fundamental Change For 5.00% Convertible Senior Notes Due 2015 9/5/2014
Depomed, Inc. (DEPO) Announces Pricing Of Upsized $300 Million Convertible Senior Notes Due 2021 9/5/2014
Inovio Pharmaceuticals (INO) To List On NASDAQ 9/4/2014
Clovis Oncology (CLVS) Announces Pricing Of $250 Million Of Convertible Senior Notes 9/4/2014
Perrigo Company (PRGO) Announces Exchange Offer For Its 1.30% Senior Notes Due 2016, 2.30% Senior Notes Due 2018, 4.00% Senior Notes Due 2023 and 5.30% Senior Notes Due 2043 9/4/2014
Alere Inc. (ALR) Declares Cash Dividend On Its Series B Convertible Perpetual Preferred Stock 9/4/2014
ReVance Therapeutics, Inc. (RVNC) Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 9/3/2014
Otonomy, Inc. (OTIC) Announces Full Exercise Of Underwriters' Option To Purchase Additional Shares 9/3/2014
BioDelivery Sciences International (BDSI) To Ring The NASDAQ Stock Market Opening Bell 9/3/2014
Horizon Discovery Group Plc: Notice Of Interim Results 9/3/2014
Clovis Oncology (CLVS) To Offer $200 Million Of Convertible Senior Notes 9/3/2014
Depomed, Inc. (DEPO) Announces Offering Of $230 Million Convertible Senior Notes Due 2021 9/3/2014
BioDelivery Sciences International (BDSI) To Ring The NASDAQ Stock Market Opening Bell 9/3/2014
Marinus Pharmaceuticals (MRNS) Announces Exercise Of Over-Allotment Option In Public Offering Of Common Stock 9/2/2014
Agile Therapeutics, Inc. To Ring The NASDAQ Stock Market Closing Bell 9/2/2014
Aurinia (ISA.TO) To Begin Trading On The NASDAQ Global Market 9/2/2014
Cellectis (ALCLS): Genome Engineering & CART Cells: At The Forefront Of Immuno-Oncology 9/2/2014
Nordic Nanovector – Subsequent Offering 9/2/2014
VentiRx Pharmaceuticals, Inc. Provides Corporate And Clinical Update 9/2/2014
Stellar Biotechnologies, Inc. Reports On Unusual Trading Activity 9/2/2014
Daxor Corporation (DXR) Announces Filing Of Form N-CSR For June 30, 2014 9/2/2014
Orexo AB (ORXOF) Has Successfully Completed Its Private Placement Of Approx. SEK 346.5 Million 8/29/2014
Advanced Cell Technology Announces 1:100 Reverse Stock Split 8/28/2014
Allenex AB: Sales +15% Jan-Jun 2014 8/28/2014
ThromboGenics NV (TBGNF) Business Update H1 2014 8/28/2014
Facing Shareholder Demands, Allergan Inc. (AGN) Reluctantly Sets A Date For Special Meeting 8/27/2014
NeuroSigma, Inc. Files Registration Statement for Proposed Initial Public Offering 8/27/2014
Sinovac Biotech Ltd. (SVA) Announces Results Of 2014 Annual General Meeting Of Shareholders 8/27/2014
Transcat, Inc. (TRNS) Increases Secured Revolving Credit Facility 8/27/2014
BioDelivery Sciences International (BDSI) To Host Investor And Analyst Event And Webcast Friday, September 5 On BUNAVAIL™ Launch And Pipeline 8/27/2014
Allergan Inc. (AGN) To Request California Federal Court Block Valeant Pharmaceuticals International (VRX) And Pershing Square From Voting Shares Acquired In Violation Of Insider Trading Laws 8/27/2014
Move Over San Francisco: Boston Showing Its Pharmaceutical Potential 8/26/2014
Mesoblast Limited (MSB.AX) Unveils Path To Bring Its Key Products To Market 8/26/2014
Viropro Inc. (VPRO) Initiates Interim Debt Financing Of Up To $500,000 8/26/2014
Wound Management Technologies, Inc. Announces Its 2014 Annual Meeting Of Shareholders 8/26/2014
Marinus Pharmaceuticals (MRNS) To Ring The Opening Bell Of The NASDAQ Stock Market 8/25/2014
Vaccinogen Completes Initial Closing Of An $80 Million Financing 8/25/2014
China Cord Blood Corporation Receives Notice Of Transaction Regarding Its 7% Senior Convertible Note Due 2017 Held By Golden Meditech 8/25/2014
Landauer (LDR) Declares Regular Cash Dividend 8/25/2014
Abbott Laboratories (ABT) Commences Tender Offer For All Outstanding Ordinary Shares And American Depositary Shares Of CFR Pharmaceuticals 8/25/2014
Asterias Biotherapeutics Announces Investor Briefing Conference Call And Webcast 8/25/2014
BioGenerator Funds Woman-led EDIS Solutions 8/25/2014
Letter To The Ampio Pharmaceuticals, Inc. (AMPE) Shareholders In Regard To The STEP Study And Ampio's Plans For The Ampion™ BLA 8/25/2014
Genmab A/S (GEN.CO) Release: Major Shareholder Announcement 8/25/2014
Pershing Square Submits Requisite Requests From Allergan Inc. (AGN) Shareholders To Call Special Meeting 8/25/2014
Easton Pharmaceuticals (OP: EAPH) Announces Financing Update; Provides Additional Due Diligence Documents To Canadian Based Brokerage Firm Towards Financing 8/25/2014
China Biologic Products Pays $87 Million For Additional 20 Percent Stake In Subsidiary 8/25/2014
Lemelson Capital Comments On Large Institutional Selling In Shares Of Ligand Pharmaceuticals Inc. (LGND) Amidst Company's Insolvency And Mounting Going Concern Risk 8/25/2014
NeoGenomics, Inc. (NGNM.OB) Announces Closing Of Recent Equity Offering And Exercise In Full Of Underwriters' Over-Allotment Option 8/22/2014
Allergan Inc. (AGN) Loses Battle To Make Shareholder Vote Moot On Valeant Pharmaceuticals International (VRX) Bid 8/22/2014
Cellectar Biosciences  (NVLT) Announces Closing Of Public Offering And Partial Exercise Of Underwriter's Over-Allotment Option 8/21/2014
Asterias Biotherapeutics Appoints Two Independent Directors And Announces Completion Of Series A Common Stock Distribution 8/21/2014
Henry Schein, Inc. (HSIC) To Present At Two Investor Conferences In September 8/21/2014
Change In The Number Of Votes Relating To BioTie Therapies Corp.'s Shares 8/21/2014
Compugen Ltd. (CGEN) Reacquires Baize’s Financial Interest In Pipeline Product Candidates 8/21/2014
Marina Biotech, Inc. (MRNA) Regains Compliance With Exchange Act Reporting Obligations 8/21/2014
Bao Hao Investment Management Co. Affiliate Takes Equity Stake In 20/20 GeneSystems, Inc. 8/21/2014
PTC Therapeutics, Inc. (PTCT) To Participate At Upcoming Investor Conferences 8/21/2014
Regeneron Pharmaceuticals, Inc. (REGN) To Ring The NASDAQ Stock Market Opening Bell 8/20/2014
Lorus Therapeutics Inc. (LRP) Announces Results Of Annual And Special Meeting Of Shareholders 8/20/2014
Enzymotec Announces An Annual General Meeting Of Shareholders 8/20/2014
Ocular Therapeutix, Inc. (OCUL) Announces Exercise Of Over-Allotment Option 8/20/2014
Adamis Pharmaceuticals (ADMP) Announces Private Placement 8/20/2014
Celladon Corporation Announces Closing Of Public Offering Of Common Stock And Exercise In Full Of Underwriters' Option To Purchase Additional Shares 8/19/2014
Immune Pharmaceuticals, Inc. Announces Approval For Listing On The NASDAQ Capital Market 8/19/2014
Regeneron Pharmaceuticals, Inc. (REGN) Announces Upcoming 2014 Investor Conference Presentations 8/19/2014
Mallinckrodt Now A Component Of The S&P 500 Index 8/19/2014
Invitation To Extraordinary General Meeting Of Shareholders Of Recipharm AB 8/19/2014
Regeneron Pharmaceuticals, Inc. (REGN) To Ring The NASDAQ Stock Market Opening Bell 8/19/2014
Northwest Biotherapeutics (NWBO) Completes The Closing Of Its $17.5 Million Convertible Note Offering 8/19/2014
Silicon Valley’s Hottest Tech Accelerator, Y Combinator, To Debut Biotech Startups 8/19/2014
H&Q Life Sciences Investors Declares Stock Distribution 8/18/2014
Resverlogix Corporation (RVX.TO) Closes Additional $30 Million From Citibank Loan 8/18/2014
TNI BioTech Provides 2nd Notice of Annual Meeting September 4, 2014 8/18/2014
Dyadic International, Inc. Files Form 10 Registration Statement 8/18/2014
Insmed Incorporated (INSM) Announces Closing Of Public Offering And Exercise Of Option To Purchase Additional Shares 8/18/2014
Cellectar Biosciences  (NVLT) Announces Pricing Of $12,500,000 Public Offering And Listing On The Nasdaq Capital Market 8/15/2014
NeoGenomics, Inc. (NGNM.OB) Announces Public Offering Of Common Stock 8/15/2014
TNI BioTech Announces An Extension To The Record Date Of Its Wholly Owned Subsidiary, Cytocom Inc., And Dividend Now Set For September 30, 2014 8/15/2014
Resverlogix Corporation (RVX.TO) Shareholders Approve Additional $30 Million From Citibank Loan 8/14/2014
Immune Pharmaceuticals, Inc. Announces Second Quarter 2014 Financial Results And Provides Update On Bertilimumab Commencement Of Phase 2 Clinical Trials 8/14/2014
VistaGen Therapeutics, Inc. Announces Reverse Stock Split 8/14/2014
Northwest Biotherapeutics (NWBO) Announces Pricing Of $17.5 Million Offering Of Convertible Notes 8/14/2014
Pressure BioSciences, Inc. (BBII) Reports Second Quarter 2014 Financial Results And Provides Business Update 8/14/2014
Novozymes, Inc. (NZYMb.CO) Increases 2014 Profit Outlook 8/14/2014
Struggling Dendreon Corporation (DNDN) Plunges After Warning Investors Of Debt Woes 8/14/2014
Celladon Corporation Announces Pricing Of Public Offering Of Common Stock 8/13/2014
Intellect Neurosciences, Inc. Issues Letter To Shareholders 8/13/2014
NanoViricides, Inc. (NNVC.PK) To Ring Opening Bell At New York Stock Exchange 8/13/2014
Insmed Incorporated (INSM) Announces Pricing Of Public Offering Of Common Stock 8/13/2014
Ligand Pharmaceuticals Inc. (LGND) Prices Offering Of $225 Million Of Convertible Senior Notes 8/13/2014
Novogen Limited (NVGN) Announces Results Of General Meeting Of Shareholders 8/13/2014
Pressure BioSciences, Inc. (BBII) To Discuss Second Quarter 2014 Financial Results And Provide A Business Update 8/13/2014
Israel's VBL Therapeutics (VBLX) Terminates NASDAQ IPO Due To Shareholder Mishap 8/12/2014
Aegerion Pharmaceuticals, Inc. (AEGR) Prices $300 Million Convertible Senior Notes Offering 8/12/2014
Apricus Biosciences (APRI) Enters Into Common Stock Purchase Agreement With Aspire Capital 8/12/2014
Ligand Pharmaceuticals Inc. (LGND) Announces Proposed Offering Of $225 Million Of Convertible Senior Notes And Announces $200 Million Share Repurchase Program 8/12/2014
Insmed Incorporated (INSM) Announces Proposed Public Offering Of Common Stock 8/12/2014
Organovo Highlights Liver Toxicology Achievement, Reports Q1 Fiscal 2015 Results 8/12/2014
Cannabis Science Inc. Increases Equity Position To 50.1% In Michigan Green Technologies LLC, Positioning Company As Leader In Evolving Michigan Medical Cannabis And Hemp Industries 8/12/2014
Big Investors Ask Drugmakers And Biotechs To Support Biosimilars 8/12/2014
Orthocell Successfully Lists On Australian Securities Exchange 8/12/2014
Aegerion Pharmaceuticals, Inc. (AEGR) Announces Intention To Offer $250 Million Of Convertible Notes 8/11/2014
Cellular Biomedicine Group (CBMG) To Ring The NASDAQ Stock Market Closing Bell 8/11/2014
TONIX Pharmaceuticals, Inc. Announces Transfer To The NASDAQ Global Market 8/11/2014
PDL BioPharma, Inc. (PDLI) Announces Delay In Filing Quarterly Report On Form 10-Q 8/11/2014
Mast Therapeutics (MSTX) Provides Corporate Update And Reports Second Quarter 2014 Financial Results 8/11/2014
Bio-Techne Declares Dividend 8/11/2014
Galapagos NV (GLPG.BR) Cash Position Of €232 M Provides Solid Basis For R&D Pipeline Investment 8/8/2014
Aegerion Pharmaceuticals, Inc. (AEGR) Grants Stock Options Under Inducement Program 8/8/2014
Advisor ISS Backs Ackman's Call For Allergan Inc. (AGN) Meeting, Event Could Support The Removal Of Directors, Sale To Valeant Pharmaceuticals International (VRX) 8/7/2014
Press Release Issued Under The Early Warning System/Sale Of Shares Of Nymox Pharmaceutical (NYMX) 8/7/2014
Celladon Corporation Announces Commencement Of Public Offering Of Common Stock 8/7/2014
Institutional Shareholder Services (ISS) Recommends Allergan Inc. (AGN) Shareholders Call A Special Meeting Of Shareholders 8/7/2014
QLT Inc. (QLTI) Announces Adoption Of Advance Notice Policy 8/7/2014
CVS Caremark Corporation (CVS) Announces Cash Tender Offers For Its 6.250% Senior Notes Due 2027, 6.125% Senior Notes Due 2039, 5.750% Senior Notes Due 2041 And 5.750% Senior Notes Due 2017 8/7/2014
Aoxing Pharmaceutical Company Inc. (AXN) Receives Notice Of Extension From NYSE MKT LLC 8/7/2014
AmerisourceBergen Corporation (ABC) Declares Quarterly Dividend 8/7/2014
Jazz Pharmaceuticals plc (JAZZ) Announces Proposed Offering Of $500 Million Of Exchangeable Senior Notes 8/7/2014
Zoetis (ZTS) Will Hold Its Inaugural Investor Day On November 18 8/5/2014
PTC Therapeutics, Inc. (PTCT) Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 8/4/2014
Telik, Inc. (TELK) Announces Plans For Special Meeting Of Stockholders And Transition To MabVax Therapeutics, Inc. 8/4/2014
Applied Genetic Technologies Corporation Announces Closing Of Public Offering And Full Exercise Of Underwriters' Option To Purchase Additional Shares 8/4/2014
Metabolix, Inc. Enters Into Private Placement Agreement With Investors To Raise $25 Million In Equity Financing 8/4/2014
Arena Pharmaceuticals, Inc. (ARNA) Provides Corporate Update And Reports Second Quarter 2014 Financial Results 8/1/2014
InVivo Therapeutics Corporation (NVIV) Announces Posting Of Management Presentation Recording From Annual Shareholders Meeting 8/1/2014
Pfizer Inc. (PFE)’s Stake In Cellectis (ALCLS)’ Capital Is Welcomed By Its Shareholders 8/1/2014
Israeli Biotech Macrocure Sets Terms for $75 Million IPO 7/31/2014